Trending Topic

4 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

Welcome to the latest edition of touchREVIEWS in Respiratory & Pulmonary Diseases. As we continually strive to deliver cutting-edge research and insightful commentary, this issue is no exception, featuring a diverse array of articles that illuminate both emerging treatments and evolving practices within the field of respiratory and pulmonary medicine. We begin with a compelling […]

touchLearning Activities

Speciality Filter

Select Specialty or Clinical Area

Clear All
Update Filters
Close Popup
Mark CompleteCompleted
BookmarkBookmarked

A recent phase 2 trial published in The Lancet Respiratory Medicine has demonstrated that benralizumab, a monoclonal antibody targeting interleukin-5 receptor-α, can significantly reduce treatment failure in eosinophilic exacerbations of asthma and COPD.

Mark CompleteCompleted
BookmarkBookmarked

The International Primary Care Respiratory Group (IPCRG), is proud to host the 8th IPCRG Scientific Meeting in Brașov, Romania, on Friday 11 and Saturday 12 April 2025. This event, in partnership with the RespiRO team and the Transilvania University of Brașov promises to bring together researchers, innovators, and industry leaders to advance respiratory care in primary health settings.

Mark CompleteCompleted
BookmarkBookmarked

The International Primary Care Respiratory Group (IPCRG) has initiated a global social movement to bring meaningful change in asthma management. The driving idea behind this initiative is a recognition that, while the current approach may feel sufficient to many, it falls short of optimal care. The IPCRG network sees clear evidence of avoidable harm and unnecessary costs in the current asthma management framework, which continue to impact lives and wellbeing.1 To counteract this, IPCRG's "Asthma Right Care" aims to inspire a shift towards better care practices by reducing both overuse and underuse of effective treatments. This means moving beyond episodic symptom relief and acute responses to establish a chronic care model that adheres to international or national asthma guidelines, prioritizing the appropriate use of anti-inflammatory inhaled medications.

Mark CompleteCompleted
BookmarkBookmarked

COP29, currently underway in Baku, is bringing together global leaders to address the multifaceted issues of climate change, with healthcare firmly on the agenda. In a speech delivered by the WHO Director-General, Dr. Tedros Adhanom Ghebreyesus, he emphasized the critical link between climate change and human health, reinforcing that the climate crisis is, at its core, a health crisis. The escalating climate emergency is no longer a distant threat; it is already affecting human lives, particularly those of vulnerable groups like women and children.

Mark CompleteCompleted
BookmarkBookmarked

Although there is limited evidence on the link between interstitial lung disease (ILD) and malnutrition, malnourished patients tend to have shorter survival rates, regardless of disease severity. A late-breaking abstract presented at ERS 2024 titled “Dietetic intervention in malnourished patients with interstitial lung disease (ILD): a pilot trial” investigated whether dietitian involvement could provide meaningful benefits to these patients, potentially laying the groundwork for further research and future clinical guidelines.

Mark CompleteCompleted
BookmarkBookmarked

A new study in the European Respiratory Journal reveals that early-life BMI trajectories significantly influence lung function outcomes in young adulthood, with abnormal BMI patterns linked to poorer respiratory health. 

Mark CompleteCompleted
BookmarkBookmarked

A new European Respiratory Society (ERS) statement on preschool wheezing disorders represents a significant update in the approach to diagnosing and managing this complex condition in young children.

Mark CompleteCompleted
BookmarkBookmarked

As we observe World Lung Day, it is crucial to reflect on the escalating impact of respiratory diseases across the globe. Chronic respiratory diseases — including chronic obstructive pulmonary disease (COPD), asthma, lung cancer, pulmonary hypertension, obstructive sleep apnea, and others — continue to rank among the leading causes of morbidity and mortality worldwide. The World Health Organization’s latest data underscores the persistence of the global respiratory crisis:

Mark CompleteCompleted
BookmarkBookmarked

A recent study published in the European Respiratory Journal has revealed new insights into the immune response in children suffering from recurrent respiratory tract infections (rRTIs).

Mark CompleteCompleted
BookmarkBookmarked

The Global Initiative for Asthma (GINA) has released its 2024 update on asthma management and prevention. This report, authored by the GINA Science Committee, brings significant updates on various topics crucial for effective asthma management.

Mark CompleteCompleted
BookmarkBookmarked

The European Commission has approved dupilumab (Regeneron and Sanofi)) as an add-on maintenance treatment for adults with uncontrolled chronic obstructive pulmonary disease (COPD) characterized by raised blood eosinophils.

Mark CompleteCompleted
BookmarkBookmarked

The World Health Organization (WHO) has released a new report detailing the severe health consequences of air pollution on global populations.

Mark CompleteCompleted
BookmarkBookmarked

A recent study published in Nature explored the awareness and understanding of third-hand smoke (THS) among medical students. 

59 mins
Sponsored Content
touchROUNDTABLE
For HCPs in: USA, Brazil, Germany, France, China, Japan, UAE

Leading experts discuss the role of different inflammatory pathways in COPD disease progression.

46 mins
Sponsored Content
touchMEETING HIGHLIGHTS
For HCPs in: USA

Watch a short video presentation on the diagnosis and assessment of COPD according to the 2024 GOLD report, focusing on clinical features and assessment goals. Then join leading experts as they discuss the latest advances in understanding COPD, originally presented by Sanofi and Regeneron Pharmaceuticals in two symposia at ERS 2023 and GOLD 2023.

Mark CompleteCompleted
BookmarkBookmarked

World Tuberculosis (TB) Day is observed annually on 24 March to raise awareness about tuberculosis and to commemorate the discovery of the Mycobacterium tuberculosis bacterium (M.tb) by Dr Robert Koch in 1882. It aims to educate people about the impact of ...

30 mins
touchTALKS
Mark CompleteCompleted
BookmarkBookmarked

Prof. Tony Mok discusses the role of KRAS mutations in solid tumours and the impact of KRASG12C inhibitors on patient outcomes.

44 mins
touchPANEL DISCUSSION
Mark CompleteCompleted
BookmarkBookmarked
Prof. Claire Hopkins, Prof. Claus Bachert, Prof. Martin Desrosiers

Watch a panel of experts discuss challenges in the diagnosis of CRSwNP and considerations for optimal management of the disease.

Load More...
touchRESPIRATORY touchRESPIRATORY

Register Now!

Explore the latest in medical education and stay current in your field. Create a free account to track your learning.

  • Save your progress for video
  • Keep track of your CME credits
  • Add personalised learning notes
  • Receive updates from course leaders and faculty
  • Be the first to hear about new and exciting interactive learning opportunities
Close Popup